Mirum Pharmaceuticals, INC. (MIRM) — 8-K Filings

8-K Filings (11)

• Mirum Pharmaceuticals Files 8-K: Material Agreement & Equity Sales — Dec 19, 2025 Risk: medium
  Mirum Pharmaceuticals, Inc. announced on December 18, 2025, the entry into a material definitive agreement and unregistered sales of equity securities. The fili
• 8-K Filing — Dec 8, 2025
• Mirum Pharmaceuticals Files 8-K — Nov 17, 2025 Risk: medium
  Mirum Pharmaceuticals, Inc. filed an 8-K on November 17, 2025, to report other events. The filing does not contain specific details about the nature of these ev
• Mirum Pharmaceuticals Files 8-K on Shareholder Votes — May 30, 2025 Risk: low
  Mirum Pharmaceuticals, Inc. filed an 8-K on May 30, 2025, reporting on matters submitted to a vote of its security holders as of May 29, 2025. The filing detail
• Mirum Pharmaceuticals Files 8-K on Financials — Jan 13, 2025 Risk: low
  Mirum Pharmaceuticals, Inc. filed an 8-K on January 13, 2025, reporting on its results of operations and financial condition. The filing also includes informati
• Mirum Pharmaceuticals Files 8-K Report — Jun 17, 2024 Risk: low
  On June 17, 2024, Mirum Pharmaceuticals, Inc. filed an 8-K report. The filing indicates that the company is providing information under "Other Events." No speci
• Mirum Pharmaceuticals Files 8-K on Shareholder Vote Matters — Jun 6, 2024 Risk: low
  Mirum Pharmaceuticals, Inc. filed an 8-K on June 6, 2024, to report on matters submitted to a vote of its security holders. The filing indicates that the compan
• Mirum Pharmaceuticals Files 8-K Report — May 31, 2024 Risk: medium
  On May 31, 2024, Mirum Pharmaceuticals, Inc. filed an 8-K report. The filing indicates that the company is providing information regarding "Other Events" withou
• Mirum Pharma Files 8-K on Financial Condition — Feb 28, 2024 Risk: low
  Mirum Pharmaceuticals, Inc. filed an 8-K on February 28, 2024, to report on its results of operations and financial condition. The filing indicates that the com
• Mirum Pharma Reports Executive Changes/Compensatory Arrangements — Jan 16, 2024
  Mirum Pharmaceuticals, Inc. filed an 8-K on January 16, 2024, reporting an event that occurred on January 11, 2024. This filing indicates a change in the compan
• Mirum Pharma Files 8-K on Operations & Financial Condition — Jan 8, 2024
  Mirum Pharmaceuticals, Inc. filed an 8-K on January 8, 2024, to report on its results of operations and financial condition, as well as Regulation FD disclosure

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX